Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hefei To Establish World’s Largest Hepatitis B Vaccine Production Base

This article was originally published in PharmAsia News

Executive Summary

According to Hefei FDA, Anhui province, the world's largest hepatitis B vaccine base will be set up in the Hefei Life Science and Technology Park. To occupy 300 mu (20 hectares) of land and factory space, it will have an annual output of 11 million hepatitis B vaccine injections. Scheduled to commence operation in 2010, the base will bring in the most advanced production technology for hepatitis B vaccines from Israel. At present, the completed phase one basic facilities have started producing recombinant human insulin injection using processes including formulation, sub-packaging and packaging. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069975

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel